BSE filing, NSE: MAFATIND. Summary written from the filing by ALFA Finder's alert engine.
Mafatlal Industries Ltd: key numbers
- Share price
- ₹108.85
- Market cap
- ₹782.7 Cr
- Revenue (annual)
- ₹3,871 Cr
- Net profit (annual)
- ₹89.98 Cr
- P/E (TTM)
- 13.3×Sector 49.0×
- Promoter holding
- 69.30%+0.00% QoQ
- FII holding
- 0.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mafatlal Industries Ltd
All →Mafatlal Industries Partnership
Mafatlal Industries signed an MoU with the Air Force Wives Welfare Association (Local) to supply combat uniform fabric, strengthening its integrated uniforms solution segment.
Mafatlal Industries Other Announcement
Mafatlal Industries Ltd filed its quarterly shareholding pattern under SEBI Regulation 31. This is a routine regulatory disclosure regarding the company's share ownership structure.
Mafatlal Industries Board Meeting Date
Mafatlal Industries will hold a board meeting on November 4, 2026, to consider and approve un-audited standalone and consolidated financial results for the quarter.
Mafatlal Industries Credit Rating
CARE Ratings upgraded Mafatlal Industries' bank facility ratings to CARE A- (Stable) and CARE A2+ (Stable). The upgrade reflects operational growth and improved liquidity.
Mafatlal Industries Other Announcement
Designated person Rajesh Dhirajlal Shrimankar sold 11,753 shares of Mafatlal Industries Ltd. This PIT disclosure is a routine regulatory compliance filing.
- Value
- ₹0.14 Cr
Mafatlal Industries Annual General Meeting
Mafatlal Industries Limited held its 112th Annual General Meeting on August 7, 2026. The meeting covered the adoption of financial statements and re-appointments of key personnel.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.